<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="ami_virus_4\PMC7261908\results\search\tropicalVirus\results.xml">
  <result pre="PPVIs against several important enveloped viruses, including HIV, influenza virus," exact="Zika" post="virus (ZIKV), dengue virus (DENV), and herpes simplex virus"/>
  <result pre="from the organelle membrane. For example, the envelope of both" exact="DENV" post="and ZIKV derives from the endoplasmic reticulum membrane (Kuhn"/>
  <result pre="organelle membrane. For example, the envelope of both DENV and" exact="ZIKV" post="derives from the endoplasmic reticulum membrane (Kuhn et al.,"/>
  <result pre="long way to put them into practice. Protein- and Peptide-Based" exact="ZIKV" post="and DENV Inactivators Flaviviruses, with a positive-sense single-stranded RNA"/>
  <result pre="to put them into practice. Protein- and Peptide-Based ZIKV and" exact="DENV" post="Inactivators Flaviviruses, with a positive-sense single-stranded RNA genome, are"/>
  <result pre="of human pathogens, including DENV, ZIKV, yellow fever virus (YFV)," exact="West Nile" post="virus (WNV), and so on (Kuno et al., 1998)."/>
  <result pre="Nile virus (WNV), and so on (Kuno et al., 1998)." exact="Zika" post="virus infection usually causes mild symptoms, such as rash,"/>
  <result pre="in some cases, such as Guillain-BarrÃ© syndrome, meningo-encephalitis and myelitis." exact="ZIKV" post="infection of pregnant women may cause microcephaly in their"/>
  <result pre="et al., 2017; Han and Mesplede, 2018). Four serotypes of" exact="DENV" post="(DENV-1, 2, 3, and 4) constitute the primary mosquito-borne"/>
  <result pre="2, 3, and 4) constitute the primary mosquito-borne viral pathogen." exact="DENV" post="is endemic in more than 100 countries worldwide, and"/>
  <result pre="million people exhibit disease symptoms (Bhatt et al., 2013). After" exact="DENV" post="infection, some individuals exhibit mild symptoms like flu, while"/>
  <result pre="area of a virion (Slon Campos et al., 2018). Taking" exact="DENV" post="as an example, the ectodomain of each E protein"/>
  <result pre="of the interaction between E and M proteins on the" exact="DENV" post="surface revealed that M protein, functioning as a pH-sensitive"/>
  <result pre="maturation (Li et al., 2008). As shown in Figure 4B," exact="DENV" post="infection is initiated by binding of domain III of"/>
  <result pre="2008; Klein et al., 2013). FIGURE 4 The structure of" exact="DENV" post="E protein in the native and fusion-intermediate states, which"/>
  <result pre="serve as sources and targets of the protein- and peptide-based" exact="DENV" post="inactivators. (A) Schematic representation of E protein composition, including"/>
  <result pre="blue, respectively), stem and transmembrane region (TM). (B) Attachment of" exact="DENV" post="E protein to the cellular receptor(s) and fusion of"/>
  <result pre="promising source and target for development of protein- and peptide-based" exact="DENV" post="inactivators. In recent years, the structure of DENV E"/>
  <result pre="and peptide-based DENV inactivators. In recent years, the structure of" exact="DENV" post="E protein has been well determined using X-ray crystallography"/>
  <result pre="et al., 2013), which has allowed researchers to rationally design" exact="DENV" post="inactivators (Chew et al., 2017). Using a physiochemical algorithm,"/>
  <result pre="hydrophobicity scale (WWIHS), together with the known structural information of" exact="DENV" post="E protein, Hrobowski et al. (2005) designed four peptides"/>
  <result pre="(DN80, DN57, DN81, and DN59) derived from different regions of" exact="DENV" post="E protein. They found that DN59, derived from the"/>
  <result pre="membrane-binding ability, could inhibit infection of all four serotypes of" exact="DENV" post="with IC50 values in the range of 2â€&quot;5 Î¼M."/>
  <result pre="results of the above studies imply that protein- and peptide-based" exact="ZIKV" post="inactivators can also originate from the stem sequence. Accordingly,"/>
  <result pre="designed and synthesized, which is derived from the stem of" exact="ZIKV" post="E protein (residues 421â€&quot;453), and similarly Z2 was shown"/>
  <result pre="Z2 was shown to inhibit infection by different strains of" exact="ZIKV" post="and other flaviviruses, including YFV and DENV with IC50"/>
  <result pre="infection by different strains of ZIKV and other flaviviruses, including" exact="YFV" post="and DENV with IC50 values between 1 and 14"/>
  <result pre="different strains of ZIKV and other flaviviruses, including YFV and" exact="DENV" post="with IC50 values between 1 and 14 Î¼M. Animal"/>
  <result pre="that Z2 could protect A129 and AG6 mice from lethal" exact="ZIKV" post="challenge; Z2 was also found to cross the placental"/>
  <result pre="to cross the placental barrier and prohibit vertical transmission of" exact="ZIKV" post="in pregnant mice. The mechanism studies suggested that Z2"/>
  <result pre="regions in E protein may also serve as sources of" exact="DENV" post="inactivators. Based on the native dimeric E structure, Costin"/>
  <result pre="to be further explored. Apart from being the source of" exact="DENV" post="inactivators, other regions of E protein can also be"/>
  <result pre="(EF for short) could inhibit the infection of all four" exact="DENV" post="serotypes, but it was the most effective against DENV-2"/>
  <result pre="96 Î¼M. Different inhibitory effect for the four serotypes of" exact="DENV" post="was possible because of the different amino acid sequence"/>
  <result pre="mechanism of action, EF peptide can be considered as a" exact="DENV" post="inactivator, as potentially confirmed by performing a virus inactivation"/>
  <result pre="thus making it another feasible target of protein- and peptide-based" exact="DENV" post="inactivators (Hung et al., 2004; Mazumder et al., 2007)."/>
  <result pre="the viral envelope. Other studies showed that M protein of" exact="DENV" post="could interact with native E protein to trigger the"/>
  <result pre="interact with native E protein to trigger the conformation of" exact="DENV" post="E protein, suggesting that peptides derived from M protein"/>
  <result pre="suggesting that peptides derived from M protein may act as" exact="DENV" post="inactivators. Panya et al. (2015) designed a novel anti-DENV"/>
  <result pre="found that it could inhibit infection of four serotypes of" exact="DENV" post="with IC50 values ranging from 24 to 31 Î¼M."/>
  <result pre="suggested that the N-terminal loop of MLH40 could interact with" exact="DENV" post="E protein to alter its native dimeric conformation. However,"/>
  <result pre="not been tested and reported. In sum, the studies on" exact="DENV" post="and ZIKV inactivators are not as comprehensive as those"/>
  <result pre="tested and reported. In sum, the studies on DENV and" exact="ZIKV" post="inactivators are not as comprehensive as those on HIV"/>
  <result pre="elucidated. Despite of these deficiencies, the design and development of" exact="DENV" post="and ZIKV inactivators can be referential paradigms for those"/>
  <result pre="of these deficiencies, the design and development of DENV and" exact="ZIKV" post="inactivators can be referential paradigms for those of newly"/>
  <result pre="viruses: HIV and influenza virus (with class I membrane fusion)," exact="ZIKV" post="and DENV (with class II membrane fusion), and HSV"/>
  <result pre="and influenza virus (with class I membrane fusion), ZIKV and" exact="DENV" post="(with class II membrane fusion), and HSV (with class"/>
  <result pre="HA1, or the conserved stem regions, such as those in" exact="DENV" post="and ZIKV E protein; and (4) for performing viral"/>
  <result pre="the conserved stem regions, such as those in DENV and" exact="ZIKV" post="E protein; and (4) for performing viral inactivation assays,"/>
  <result pre="for evaluating inactivation activities of the PPVIs against HIV-1 and" exact="ZIKV" post="(Lu et al., 2012; Yu et al., 2017). In"/>
  <result pre="IPLRGAFINGRWDSQCHRFSNGAIACA H1 HA conserved stem HNBD# Holthausen et al., 2017" exact="ZIKV" post="inactivators DN59 E protein stem (aa 692â€&quot;724): MAILDDTAWDFGSLGGVFTSIGKALHQ VFGAIY"/>
  <result pre="ZIKV inactivators DN59 E protein stem (aa 692â€&quot;724): MAILDDTAWDFGSLGGVFTSIGKALHQ VFGAIY" exact="DENV" post="lipid membrane 4.8 Î¼M (DENV-2) Schmidt et al., 2010a,"/>
  <result pre="al., 2012 Z2 E protein stem (aa 421â€&quot;453): MAVLGDTAWDFGSVGGALNSLGKGIH QIFGAAF" exact="ZIKV" post="lipid membrane 2.52 Î¼M Yu et al., 2017 HSV"/>
  <result pre="and influenza virus part of the manuscript. SJ revised the" exact="ZIKV" post="and DENV, HSV, and the discussion part of the"/>
  <result pre="congenital zika virus infection.EBioMedicine20193â€&quot;201. 10.1016/j.ebiom.2017.04.02928583742 CulshawA.MongkolsapayaJ.ScreatonG. (2018). The immunology of" exact="Zika" post="Virus.F1000Res.7:20310.12688/f1000research.12271.1 DaarE. S.LiX. L.MoudgilT.HoD. D. (1990). High concentrations of"/>
  <result pre="Dengue.Lancet3701644â€&quot;1652. 10.1016/S0140-6736(07)61687-017993365 HanY.MespledeT. (2018). Investigational drugs for the treatment of" exact="Zika" post="virus infection: a preclinical and clinical update.Expert Opin. Investig."/>
  <result pre="M.GarryR. F.MichaelS. F. (2005). Peptide inhibitors of dengue virus and" exact="West Nile" post="virus infectivity.Virol. J.2:4910.1186/1743-422X-2-49 HuertaV.ChineaG.FleitasN.SarriaM.SanchezJ.ToledoP.et al. (2008). Characterization of the"/>
  <result pre="A peptide inhibitor derived from the conserved ectodomain region of" exact="DENV" post="membrane (M) protein with activity against dengue virus infection.Chem."/>
  <result pre="prior baloxavir treatment, Japan, January 2019.Euro Surveill.24:190017010.2807/1560-7917.ES.2019.24.12.1900170 TianY. S.ZhouY.TakagiT.KameokaM.KawashitaN. (2018)." exact="Dengue" post="virus and its inhibitors: a brief review.Chem. Pharm. Bull.66191â€&quot;206."/>
  <result pre="XuM.LeeE. M.WenZ.ChengY.HuangW. K.QianX.et al. (2016). Identification of small-molecule inhibitors of" exact="Zika" post="virus infection and induced neural cell death via a"/>
  <result pre="10.3390/v501035223340380 YuY.DengY. Q.ZouP.WangQ.DaiY.YuF.et al. (2017). A peptide-based viral inactivator inhibits" exact="Zika" post="virus infection in pregnant mice and fetuses.Nat. Commun.8:1567210.1038/ncomms15672 ZamanR.IslamR."/>
 </snippets>
</snippetsTree>
